Sorin collects EU approval for its Intensia family of cardiac devices

Intensia ICD and CRT-D implant--Courtesy of Sorin

Notching another CE mark in its cardiac cache, Italian devicemaker Sorin nabbed European approval for its Intensia family of implantable cardiac defibrillator and cardiac resynchronization therapy (CRT) devices. The batch of devices includes both a single-chamber and a dual-chamber implant, as well as one with Sorin's self-adjusting SonR algorithm, which has shown in the clinic to improve CRT response by 23%. And all of the Intensia devices use the DF-4 high-voltage connector, which requires only one connection as opposed to two or three and has become an industry standard. Sorin is expecting big growth next year with its focus on new products, and just last month the company picked up another CE mark for its stentless aortic valve replacement Freedom Solo Smart. Release

Suggested Articles

Boehringer Ingelheim tapped Healx to help identify new drug indications and leverage its AI to explore R&D options in neurological diseases.

CMR Surgical will have a new CEO at the top of the year, as it kicks off the global launch of its modular Versius system while awaiting FDA approval.

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.